benzyl 2-deoxy-1,4-dithio-3,5-di-O-p-toluoyl-D-erythro-pentofuranoside | 134939-04-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: benzyl 2-deoxy-1,4-dithio-3,5-di-O-p-toluoyl-D-erythro-pentofuranoside
• 英文别名: [(2R,3S)-5-benzylsulfanyl-3-(4-methylbenzoyl)oxythiolan-2-yl]methyl 4-methylbenzoate
• CAS: 134939-04-1
• 化学式: C₂₈H₂₈O₄S₂
• 分子量: 492.66
• InChiKey: CNWNVZADWSZYJH-LHJLODMPSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.3
• 重原子数：
  34
• 可旋转键数：
  10
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  103
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  benzyl 2-deoxy-1,4-dithio-3,5-di-O-p-toluoyl-D-erythro-pentofuranoside 在 ammonium sulfate 、 三甲基氯硅烷 、 三氟甲磺酸三甲基硅酯 、 sodium methylate 、 六甲基二硅氮烷 作用下， 以 甲醇 、 溶剂黄146 为溶剂， 生成 2'-deoxy-5-ethynyl-4'-thiouridine
  参考文献：
  名称：

  Synthesis and Anti-Herpes Virus Activity of 2‘-Deoxy-4‘-thiopyrimidine Nucleosides

  摘要：

  A series of 5-substituted 2'-deoxy-4'-thiopyrimidine nucleosides was synthesized and evaluated as potential antiviral agents. A number of analogues such as 2'-deoxy-5-propyl-4'-thiouridine (3ii), 2'-deoxy-5-isopropyl-4'-thiouridine (3iii), 5-cyclopropyl-2'-deoxy-4'-thiouridine (3iv), 2'-deoxy-4'-thio-5-vinyluridine (3viii), and 5-(2-chloroethyl)-2'-deoxy-4'-thiouridin (3xx) were found to be highly active against herpes simplex virus type-1 (HSV-1) and varicella tester virus (VZV) in vitro with no significant cytotoxicity. The compound with the broadest spectrum of activity was 2'-deoxy-5-ethyl-4'-thiouridine (3i) which showed significant activity against HSV-1, HSV-2, and VZV.

  DOI：

  10.1021/jm950029r
• 作为产物：
  描述：

  benzyl 3,5-di-O-benzyl-2-deoxy-1,4-dithio-D-erythro-pentofuranoside 在 吡啶 、 三氯化硼 作用下， 以 二氯甲烷 为溶剂， 反应 6.0h， 生成 benzyl 2-deoxy-1,4-dithio-3,5-di-O-p-toluoyl-D-erythro-pentofuranoside
  参考文献：
  名称：

  一些4'-硫代-2'-脱氧核苷类似物的合成和抗病毒活性。

  摘要：

  从苄基3,5-二-O-苄基-2-脱氧-1,4-二硫代-D-赤藓基呋喃呋喃糖苷（4）开始，合成了以下2'-脱氧核苷类似物：4'-硫代胸苷（8 ），3′-叠氮基-4′-硫代脱氧胸苷（10）和（E）-5-（2-溴乙烯基）-4′-硫代2′-脱氧尿苷（22）。第一种化合物是有毒的，第二种化合物是无毒的，也没有可检测的生物学活性，第三种化合物是无毒的，并且对某些疱疹病毒具有显着的活性。

  DOI：

  10.1021/jm00113a016

文献信息

• The synthesis and antiviral activity of some 4'-thio-2'-deoxy nucleoside analogs
  作者：Michael R. Dyson、Paul L. Coe、Richard T. Walker

  DOI：10.1021/jm00113a016

  日期：1991.9

  4-dithio-D-erythro- pentofuranoside (4), the following 2'-deoxy nucleoside analogues have been synthesized: 4'-thiothymidine (8), 3'-azido-4'-thio- deoxythymidine (10), and (E)-5-(2-bromovinyl)-4'-thio-2'-deoxyuridine (22). The first compound is toxic, the second is not toxic nor has detectable biological activity, and the third is not toxic and has significant activity against some herpesviruses.

  从苄基3,5-二-O-苄基-2-脱氧-1,4-二硫代-D-赤藓基呋喃呋喃糖苷（4）开始，合成了以下2'-脱氧核苷类似物：4'-硫代胸苷（8 ），3′-叠氮基-4′-硫代脱氧胸苷（10）和（E）-5-（2-溴乙烯基）-4′-硫代2′-脱氧尿苷（22）。第一种化合物是有毒的，第二种化合物是无毒的，也没有可检测的生物学活性，第三种化合物是无毒的，并且对某些疱疹病毒具有显着的活性。
• The Synthesis and Biological Activity of Certain 4'-Thionucleosides
  作者：John Secrist、William Parker、Kamal Tiwari、Lea Messini、Sue Shaddix、Lucy Rose、L. Lee Bennett、John Montgomery

  DOI：10.1080/15257779508012449

  日期：1995.5.1

  Abstract Results are presented on the synthesis and biological activity of several types of 4′-thionucleosides as potential anticancer agents. Detailed studies on the mechanism of action of 4′-thiothymidine are also presented.

  摘要介绍了几种类型的4'-硫代核苷作为潜在抗癌剂的合成和生物学活性。还介绍了有关4'-硫代胸苷的作用机理的详细研究。
• Antiviral pyrimidine nucleosides
  申请人：THE UNIVERSITY OF BIRMINGHAM

  公开号：EP0409575A1

  公开（公告）日：1991-01-23

  Pyrimidine 4′-thionucleosides of the formula I wherein Y is hydroxy or amino, and X is chloro, bromo, iodo, trifluoromethyl, C₂₋₆ alkyl, C₂₋₆ alkenyl, C₂₋₆ haloalkenyl or C₂₋₆ alkynyl and physiologically functional derivatives thereof. These compounds have utility as anti-viral agents.

  式 I 的嘧啶 4′-硫代核苷 其中 Y 是羟基或氨基，X 是氯、溴、碘、三氟甲基、C₂₋₆ 烷基、C₂₋₆ 烯基、C₂₋₆ 卤代烯基或 C₂₋₆ 烷基及其生理功能衍生物。这些化合物可用作抗病毒剂。
• Further antiviral pyrimidine nucleosides
  申请人：THE UNIVERSITY OF BIRMINGHAM

  公开号：EP0421777A1

  公开（公告）日：1991-04-10

  Pyrimidine 4′-thionucleosides of the formula (I) where B¹ is a pyrimidine base; and either (a) R² is hydrogen and R³ is hydroxy or fluoro, or (b) R² is hydroxy and R³ is hydrogen, hydroxy or fluoro, or (c) R² is fluoro and R³ is hydrogen or hydroxy, or (d) R² and R³ together form a carbon-carbon bond; and physiologically functional derivatives thereof and processes for their production. Preferably, the base B¹ is of the formula (II) wherein Y is hydroxy or amino, monoalkylamino or dialkylamino; and X is halogen, alkoxy, alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, amino, monoalkylamino, dialkylamino, cyano or nitro. The compounds are useful in the treatment of viral infections.

  式(I)的嘧啶-4′-硫代核苷 其中 B¹ 是嘧啶碱； (a) R² 是氢，R³ 是羟基或氟、 或 (b) R² 是羟基，R³ 是氢、羟基或氟、 或 (c) R² 是氟，R³ 是氢或羟基、 或 (d) R² 和 R³ 共同形成碳-碳键；以及其生理功能衍生物及其生产工艺。碱 B¹ 最好为式 (II) 其中 Y 是羟基或氨基、单烷基氨基或二烷基氨基；X 是卤素、烷氧基、烷基、卤代烷基、烯基、卤代烯基、炔基、氨基、单烷基氨基、二烷基氨基、氰基或硝基。这些化合物可用于治疗病毒感染。
• Basnak; Otter; Duncombe, Nucleosides and Nucleotides, 1998, vol. 17, # 1-3, p. 29 - 38
  作者：Basnak、Otter、Duncombe、Westwood、Pietrarelli、Hardy、Mills、Rahim、Walker

  DOI：——

  日期：——